Press release
Radiation-Induced Esophagitis Market is projected to reach USD 831 million by 2034
Radiation-Induced Esophagitis
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/71349
Radiation-induced esophagitis is a common and often dose-limiting complication seen in patients receiving radiotherapy for lung cancer, esophageal cancer, lymphoma, and mediastinal tumors. The condition results from mucosal injury due to ionizing radiation, leading to inflammation, pain, dysphagia, odynophagia, and nutritional impairment. Severe cases can significantly reduce patient adherence to cancer treatment and negatively affect clinical outcomes.
Key Market Highlights
• 2024 Market Size: USD 412 million
• 2034 Forecast: USD 831 million
• CAGR (2025-2034): 7.2%
• Highest-Risk Patients: Lung cancer & esophageal cancer patients
• Fastest-Growing Therapy Segment: Anti-inflammatory & mucosal-protective agents
Epidemiology & Patient Burden
1. Incidence
Radiation-induced esophagitis occurs in:
• 30-70% of patients undergoing thoracic radiotherapy
• Up to 90% of patients receiving concurrent chemoradiation for lung cancer
2. Cancer Types Driving Demand
Key indications contributing to the patient pool:
• Non-small cell lung cancer (NSCLC)
• Small cell lung cancer (SCLC)
• Esophageal cancer
• Lymphomas requiring mediastinal irradiation
• Metastatic thoracic tumors
3. Impact on Treatment Outcomes
• Causes interruption or dose reduction of radiotherapy
• Leads to hospitalization in severe cases
• Often results in weight loss, dehydration, and poor treatment tolerance
Market Growth Drivers
1. Growing Thoracic Radiotherapy Procedures
Advances such as IMRT, SBRT, and proton therapy have increased radiotherapy utilization for lung and esophageal cancers.
2. Rising Cancer Incidence Worldwide
Lung cancer remains among the top causes of cancer deaths globally, fueling treatment demand.
3. Increased Use of Chemoradiation
Concurrent chemotherapy significantly elevates the risk and severity of esophagitis, increasing supportive-care utilization.
4. Advancements in Mucosal-Protective Formulations
Newer agents aim to:
• Reduce inflammation
• Protect esophageal lining
• Enhance healing
• Prevent interruptions in oncology treatment
5. Improved Symptom Management Strategies
Multi-modal approaches combining analgesics, topical anesthetics, and anti-inflammatory drugs are gaining adoption.
Market Restraints
• Underdiagnosis of mild-to-moderate cases
• Limited approved, targeted therapies
• Adverse effects associated with systemic corticosteroids
• Low awareness in low-income healthcare settings
Market Opportunities
1. Novel Radioprotective Agents
Increasing R&D in agents that shield esophageal mucosa from radiation injury.
2. Growth of Proton Therapy Centers
Proton therapy reduces off-target dose exposure, yet supportive-care demand remains high for combination therapies.
3. Digital Symptom-Tracking Tools
Remote monitoring helps detect worsening esophagitis early.
4. Topical & Oral Protective Gels
New mucoadhesive formulations offer promising symptom relief.
5. Nutritional Support & Clinical Nutrition Products
A critical adjunct market driven by dysphagia and odynophagia.
Segmentation Overview
By Drug Class
• Anti-inflammatory agents
• Mucosal protectants
• Topical anesthetics
• Proton pump inhibitors & antacids
• Steroids
• Antimicrobial agents (for severe cases)
• Nutritional supplements
By Severity Type
• Mild
• Moderate
• Severe
By Route of Administration
• Oral
• Topical
• Injectable
• Enteral nutrition support
By End User
• Hospitals
• Cancer centers
• Radiation therapy clinics
• Specialty oncology pharmacies
Explore Full Report here: https://exactitudeconsultancy.com/reports/71349/radiation-induced-esophagitis-market
Regional Insights
North America - Largest Market
High prevalence of lung cancer, advanced radiotherapy infrastructure, strong supportive-care product adoption.
Europe - Strong Treatment Protocols
Widespread use of chemoradiation and structured symptom-management guidelines.
Asia Pacific - Fastest Growth
Rising tobacco-related cancer incidence and expanding radiotherapy centers.
Latin America - Moderate Growth
Increasing investments in oncology treatment and supportive care.
Middle East & Africa - Emerging
Growing radiotherapy capacity and improving access to cancer therapies.
Competitive Landscape
Key companies active in the radiation-induced esophagitis treatment landscape include:
• Pfizer
• GlaxoSmithKline
• Bayer
• Dr. Reddy's Laboratories
• Takeda
• Sun Pharma
• Mylan
• Perrigo
• Fresenius Kabi
• Novartis
Focus areas include mucosal protectants, anti-inflammatory formulations, anesthetic gels, and nutritional supplements.
Recent Market Developments
• Clinical trials evaluating radioprotective agents for reducing esophageal toxicity
• Novel mucoadhesive gels and barrier-forming agents entering commercialization
• Integration of AI-based radiotherapy planning to reduce esophageal exposure
• Improved nutrition intervention protocols for patients with severe dysphagia
Future Outlook (2025-2034)
The Radiation-Induced Esophagitis Market is set for sustained expansion as:
• Thoracic radiotherapy adoption increases worldwide
• Cancer incidence continues rising
• New mucosal-protective and anti-inflammatory agents enter the market
• Supportive oncology care grows as a major treatment pillar
• Digital symptom assessment tools gain usage
By 2034, the market is projected to double, reaching USD 831 million.
This report is also available in the following languages : Japanese (放射線誘発性食道炎市場), Korean (방사선 유발 식도염 시장), Chinese (放射性食管炎市场), French (Marché de l'œsophagite radio-induite), German (Markt für strahleninduzierte Ösophagitis), and Italian (Mercato dell'esofagite indotta dalle radiazioni), etc.
Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @ https://exactitudeconsultancy.com/request-sample/71349
Our More Reports:
Opioid Use Disorder Market
https://exactitudeconsultancy.com/reports/70804/opioid-use-disorder-market
Substance Use Disorder Market
https://exactitudeconsultancy.com/reports/70806/substance-use-disorder-market
Cannabis Use Disorder Market
https://exactitudeconsultancy.com/reports/70944/cannabis-use-disorder-market
Schizoaffective Disorder Market
https://exactitudeconsultancy.com/reports/71022/schizoaffective-disorder-market
About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/
https://www.thehealthanalytics.com/
https://www.analytica.global/
https://www.marketintelligencedata.com/
https://www.marketinsightsreports.com/
https://exactitudeconsultancy.com/
Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Radiation-Induced Esophagitis Market is projected to reach USD 831 million by 2034 here
News-ID: 4309637 • Views: …
More Releases from Exactitude Consultancy
Alport Syndrome Market Forecasted to Surge in Coming Years, 2024-2034
Market Overview
The Alport Syndrome Market is gradually expanding as rising diagnostic awareness and improved genetic testing enable earlier identification of this rare, inherited kidney disorder. Alport syndrome is primarily caused by mutations in the COL4A3, COL4A4, or COL4A5 genes, affecting type IV collagen and leading to progressive kidney disease, hearing loss, and ocular abnormalities.
Increased adoption of next-generation sequencing (NGS), newborn screening initiatives, and a growing focus on early intervention strategies…
Post-Transplant Lymphoproliferative Disorder (PTLD) Market is projected to reach …
The global Post-Transplant Lymphoproliferative Disorder (PTLD) Market was valued at USD 1.12 billion in 2024 and is projected to reach USD 2.31 billion by 2034, growing at a CAGR of 7.4% during the forecast period (2025-2034). Growth is driven by rising global organ transplantation volumes, increased longevity of transplant recipients, wider availability of immunosuppressive therapies, and heightened clinical vigilance for Epstein-Barr virus (EBV)-associated malignancies.
Download Full PDF Sample Copy of Market…
Adrenoleukodystrophy (ALD) Market Opportunities in 2034
Market Overview
The Adrenoleukodystrophy (ALD) Market is growing steadily as improvements in newborn screening, genetic diagnostics, and awareness of rare neurodegenerative disorders lead to earlier detection and clinical intervention.
ALD is a genetically inherited X-linked disorder caused by mutations in the ABCD1 gene, leading to the toxic accumulation of very long-chain fatty acids (VLCFAs) in the brain, adrenal glands, and spinal cord. The condition manifests in multiple forms, including childhood cerebral…
Plaque Psoriasis Market is projected to reach USD 41.27 billion by 2034
The global Plaque Psoriasis Market was valued at USD 21.84 billion in 2024 and is projected to reach USD 41.27 billion by 2034, expanding at a CAGR of 6.6% during the forecast period (2025-2034). Growth is driven by the strong adoption of biologics, rapid expansion of IL-17 and IL-23 inhibitor classes, rising psoriasis prevalence worldwide, and increasing use of targeted oral therapies for long-term disease control.
Download Full PDF Sample Copy…
More Releases for Radiation
Nuclear Grade Protection Fearless Radiation Demystifying TSTCABLES Radiation Res …
Image: https://lh3.googleusercontent.com/pw/AP1GczMn7NxsgSGWxZ5D96ZfGP-7m_QblX0hcD6fsOEtPPc3C1fGkdnHJ-VQ5UZZ1B-Ol57Q7T3GFjs7Cckj1tiiQGRmWCR8mYk2pKAOTvoGx0j9jOZgL5aGvvlET_hEFWGAP_0U_Idc4JybB5oeDMpZO5I7=w600-h400-s-no-gm?authuser=0
Radiation-resistant PEEK (polyether ether ketone) cables [https://www.tstcables.com/product-category/product-by-material/peek-cable/] are high performance cables designed for extreme environments that take advantage of the excellent physical, chemical and electrical properties of the PEEK material and are specifically optimised to withstand the effects of the radiation environment. Below TST CABLES gives you an overview of the world's latest technology in radiation resistant PEEK cables.
Core Material Properties of Radiation Resistant Cables
PEEK cables [https://www.tstcables.com/product-category/product-by-material/peek-cable/] (polyether ether…
Radiation Dose Management Market - Radiation Dose Tracking Excellence: Elevating …
Newark, New Castle, USA: The "Radiation Dose Management Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Radiation Dose Management Market: https://www.growthplusreports.com/report/radiation-dose-management-market/8706
This latest report researches the industry structure,…
Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market 2022 | …
The Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) market research report delivers accurate data and innovative corporate analysis, helping organizations of all sizes make appropriate decisions. The Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) report also incorporates the current and future global market outlook in the emerging and developed markets. Moreover, the report also investigates regions/countries expected to witness the fastest growth rates during the forecast period.
The Radiation Toxicity…
Radiation Proctitis Treatment Market Growing Up By Indication: Acute Radiation P …
Acumen Research and Consulting has announced the addition of the "Radiation Proctitis Treatment Market” report to their offering.
The Radiation Proctitis Treatment Market Report 2018 is an in depth study analyzing the current state of the Radiation Proctitis Treatment Market. It provides brief overview of the market focusing on definitions, market segmentation, end-use applications and industry chain analysis. The study on Radiation Proctitis Treatment Market provides analysis of China market covering…
Radiation Dose Management Market: Safety Concerns against Adverse Effects of Rad …
Transparency Market Research has published a new report titled, “Radiation Dose Management Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026”. According to the report, the global radiation dose management market was valued at US$ 143.2 Mn in 2017 and is projected to expand at a CAGR of 26.7% from 2018 to 2026 to reach US$ 1,361.5 Mn in 2026.
Read Report Overview - https://www.transparencymarketresearch.com/radiation-dose-management-market.html
Rise in prevalence…
Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market …
QY Market Insights added Latest Research Report titled Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market 2018 by Manufacturers, Regions, Product Type and Application, Forecast to 2025 to its Large Report database. The study provides information on market trends and development, drivers, capacities, technologies, and on the changing capital structure of the Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market.
Get Free Sample Report at: https://www.qymarketinsights.com/report-detail/54739/request-sample
The Report highlights key…
